Question 1

What specific support will I receive if I participate in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Treating the Partners of Drug Using Pregnant Women: Stage II clinical trial (NCT00496990). Contact the study team or your healthcare provider for specific answers.

Question 2

How does the new treatment compare to the standard support group?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Treating the Partners of Drug Using Pregnant Women: Stage II clinical trial (NCT00496990). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects or challenges of participating?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Treating the Partners of Drug Using Pregnant Women: Stage II clinical trial (NCT00496990). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to come in for visits and urine tests?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Treating the Partners of Drug Using Pregnant Women: Stage II clinical trial (NCT00496990). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens after the study ends? Will I continue to receive support?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Treating the Partners of Drug Using Pregnant Women: Stage II clinical trial (NCT00496990). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any risks I should be aware of before joining?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Treating the Partners of Drug Using Pregnant Women: Stage II clinical trial (NCT00496990). Contact the study team or your healthcare provider for specific answers.

What this study is about